Early anti-VEGF Therapy Intervention for Retinal Vein Occlusio
Phase 4
- Conditions
- Retinal vein occlusion
- Registration Number
- JPRN-UMIN000026173
- Lead Sponsor
- Kyoto Prefectural Univerisity of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. prior laser treatment, surgery, local steroid injection or anti-VEGF drug administration 2. bilateral retinal vein occlusion 3. uncontrolled glaucoma 4. uncontrolled systemic hypertension 5. other retinal disorders
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean change from baseline best corrected visual acuity and macular retinal sensitivity at month 12.
- Secondary Outcome Measures
Name Time Method Mean number of intravitreal injection at month 12. Mean change from baseline central retinal thickness (CRT) at month 12. Mean change from baseline best corrected visual acuity and macular retinal sensitivity at month 6. ocular serious adverse event.